Business Context and Reporting Period
This Form 8-K Current Report is filed by ChromaDex Corporation (not Niagen Bioscience, Inc.) for the period ending October 27, 2010. The filing discloses the entry into a material definitive indemnification agreement and the appointment of a new executive officer.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses on corporate governance and executive compensation arrangements rather than financial performance.
Material Changes
- Executive Appointment: William F. Spengler was appointed as President, effective November 15, 2010. He reports to Frank Jaksch, Jr., who retains the titles of CEO and Chairman.
- Indemnification: The Company entered into a form of Indemnification Agreement with all directors and executive officers, effective October 27, 2010, providing indemnification to the fullest extent permitted by law and advancing expenses for legal defense.
Guidance, Outlook, and Compensation Details
The filing details the Employment Agreement for the new President, William F. Spengler:
- Base Salary: $220,000 annually.
- Bonus: Eligible for annual cash bonuses up to 100% of base salary based on performance targets.
- Equity Grant: Options to purchase 2,000,000 shares (50% time-vested over four years; 50% performance-vested).
- Restricted Stock: Eligible to purchase 1,000,000 restricted shares vesting on November 15, 2013, contingent on continuous employment and the stock price increasing by at least three times the fair market value on November 15, 2010.
- Severance: Provisions include 12 months of base salary and benefits for termination without "Cause" or for "Good Reason," and a lump sum of 12 months' salary in the event of a "Cessation of Business."
Investor Verification Checklist
- Verify the exact vesting conditions and performance targets for the 2,000,000 stock options and 1,000,000 restricted shares granted to Mr. Spengler.
- Confirm the total dilution impact of the 3,000,000 shares of equity granted to the new President.
- Review the definitions of "Cause," "Good Reason," and "Cessation of Business" in the Employment Agreement to understand severance triggers.
- Check subsequent filings for the actual start date of Mr. Spengler's tenure and any changes to the compensation structure.